Vertex Pharmaceuticals Incorporated
VRTX
•Stock Analysis$441.30
+0.00 (+0.00%)• Live
Vertex Pharmaceuticals Incorporated Analysis Dashboard - Stock Analysis and Financial Metrics
Historical Prices
for Vertex Pharmaceuticals Incorporated
Key Financial Metrics
for Vertex Pharmaceuticals Incorporated
P/E Ratio
-117.54
Revenue Growth
+11.66%
EPS Growth
-114.80%
Market Cap
$116.19B
Dividend Yield
0.00%
Debt/Equity
0.10
ROIC
-12.80%
FCF Yield
-1.08%
View additional metrics
Valuation
P/B Ratio7.05
EV/Sales10.19
Financial Health
Current Ratio2.65
Return on Assets-4.63%
Analyst Recommendations
for Vertex Pharmaceuticals Incorporated
54 analysts
Consensus: Buy
About
for Vertex Pharmaceuticals Incorporated
Company Details
for Vertex Pharmaceuticals Incorporated
Sector
Healthcare
Industry
Biotechnology
CEO
Reshma Kewalramani FASN,
Employees
6,100
Market Cap
113.32B
Exchange
NASDAQ Global Select
IPO Date
July 24, 1991
Website
www.vrtx.comCIK
0000875320
ISIN
US92532F1003
CUSIP
92532F100
Country
US
Balance Sheet
for Vertex Pharmaceuticals Incorporated
Cash Flow Statement
for Vertex Pharmaceuticals Incorporated
Income Statement
for Vertex Pharmaceuticals Incorporated
News
No news available at the moment.